Cortellis Alternative: Daily Trial Monitoring Without the Enterprise Contract

Cortellis Clinical Trials Intelligence by Clarivate is a comprehensive platform — but at $20,000+/year, it prices out most teams. DataLookout focuses on the feature pharma BD teams use most: knowing when trials change.

What Cortellis does well

Cortellis is a full competitive intelligence platform. It combines clinical trial data with drug pipeline analysis, patent landscapes, regulatory intelligence, and deal data. For large pharma teams that need all of these in one place, it's a strong choice.

• Comprehensive drug pipeline database with proprietary data
• Patent landscape analysis and regulatory tracking
• Deal and licensing intelligence
• Analyst-curated content and reports

Where DataLookout fits

Most pharma BD professionals don't need all of Cortellis. They need to know one thing: did anything change in my competitors' trials today?

DataLookout monitors ClinicalTrials.gov daily and tells you exactly what changed — a trial started recruiting, enrollment increased, a primary endpoint was modified, new sites opened. Each change is classified as critical, notable, or minor so you know what matters.

If you need revenue forecasts and patent data, Cortellis is the right tool. If you need daily trial change monitoring at a price that doesn't require VP approval, DataLookout is built for that.

Who switches to DataLookout

• Small and mid-size biotech teams that can't justify $20K+/year for trial monitoring alone
• BD professionals at larger pharma who need a personal monitoring layer alongside enterprise tools
• Investors and analysts who track specific sponsors or therapeutic areas
• Teams between enterprise subscriptions who need immediate coverage